OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - GSK PLC Share Price

Certificat

DE000SN7WZF7

Real-time Bid/Ask 10:11:46 01/07/2024 BST
3.94 EUR / 3.95 EUR -2.59% Intraday chart for OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - GSK PLC
Current month-40.62%
1 month-40.96%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart GSK PLC
Chart OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - GSK PLC
Date Price Change
01/07/24 3.92 -3.21%
28/06/24 4.05 -0.25%
27/06/24 4.06 -17.14%
26/06/24 4.9 -0.81%
25/06/24 4.94 -1.00%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 08:58 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying GSK PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SN7WZF
ISINDE000SN7WZF7
Date issued 05/08/2022
Strike 1,190 p
Maturity Unlimited
Parity 1 : 1
Emission price 6.75
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.27
Lowest since issue 2
Spread 0.01
Spread %0.25%

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
15.3 GBP
Average target price
20.28 GBP
Spread / Average Target
+32.62%
Consensus